{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:49:46Z","timestamp":1790383786407,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantationreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.trre.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T11:30:35Z","timestamp":1502710235000},"page":"232-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Osteoporosis following heart transplantation and immunosuppressive therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-0801","authenticated-orcid":false,"given":"Eveline","family":"L\u00f6fdahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"R\u00e5degran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2017.08.002_bb0005","first-page":"147","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Gupta","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2017.08.002_bb0010","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.trre.2015.02.005","article-title":"Immunosuppressive therapies after heart transplantation\u2014the balance between under- and over-immunosuppression","volume":"29","author":"Soderlund","year":"2015","journal-title":"Transplant Rev"},{"key":"10.1016\/j.trre.2017.08.002_bb0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/tri.12284","article-title":"Acute cellular rejection the first year after heart transplantation and its impact on survival: a single-centre retrospective study at Skane University Hospital in Lund 1988\u20132010","volume":"27","author":"Soderlund","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report\u20142012","volume":"31","author":"Stehlik","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy: the Achilles' heel of heart transplantation","volume":"68","author":"Chih","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.trre.2017.08.002_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/tri.12710","article-title":"Chronic kidney disease after heart transplantation: a single-centre retrospective study at Skane University Hospital in Lund 1988\u20132010","volume":"29","author":"Soderlund","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1053-2498(03)00186-4","article-title":"The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report\u20142003","volume":"22","author":"Taylor","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0045","first-page":"569","article-title":"Diagnosis, and therapy, March 7\u201329, 2000: highlights of the conference","volume":"94","author":"NIH Consensus Development Panel on Osteoporosis Prevention","year":"2001","journal-title":"South Med J"},{"key":"10.1016\/j.trre.2017.08.002_bb0050","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality \u2014 the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2016.08.011","article-title":"Diagnostic devices for osteoporosis in the general population: a systematic review","volume":"92","author":"Hoiberg","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.trre.2017.08.002_bb0060","series-title":"Report of a WHO study group","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","volume":"843","year":"1994"},{"key":"10.1016\/j.trre.2017.08.002_bb0065","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","article-title":"Osteoporosis in young adults: pathophysiology, diagnosis, and management","volume":"23","author":"Ferrari","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"Biomark Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0075","doi-asserted-by":"crossref","first-page":"421746","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0080","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","article-title":"Excess mortality following hip fracture: a systematic epidemiological review","volume":"20","author":"Abrahamsen","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2017.08.002_bb0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.168.7.735","article-title":"Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study","volume":"168","author":"Lim","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archinternmed.2008.526","article-title":"Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative","volume":"169","author":"Carbone","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1525-139X.2007.00319.x","article-title":"Osteoporosis and chronic kidney disease","volume":"20","author":"Gal-Moscovici","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/j.trre.2017.08.002_bb0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0110","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1073\/pnas.0508480102","article-title":"Calcineurin regulates bone formation by the osteoblast","volume":"102","author":"Sun","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2017.08.002_bb0115","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00415.2005","article-title":"Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts","volume":"292","author":"Sun","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.trre.2017.08.002_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10067-006-0315-1","article-title":"Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures","volume":"26","author":"Gourlay","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trre.2017.08.002_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01623380","article-title":"Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study","volume":"3","author":"Chavassieux","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0130","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.trre.2017.08.002_bb0135","doi-asserted-by":"crossref","first-page":"G92","DOI":"10.1152\/ajpgi.00317.2006","article-title":"Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6","volume":"292","author":"Huybers","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trre.2017.08.002_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","article-title":"Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives","volume":"1","author":"Seibel","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.trre.2017.08.002_bb0145","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.trre.2017.08.002_bb0150","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/endo.139.3.5778","article-title":"Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells","volume":"139","author":"Rubin","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.trre.2017.08.002_bb0155","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.trre.2017.08.002_bb0160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-104-5-648","article-title":"Reduction of serum testosterone levels during chronic glucocorticoid therapy","volume":"104","author":"MacAdams","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0165","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0039-128X(78)90074-0","article-title":"Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells","volume":"32","author":"Hsueh","year":"1978","journal-title":"Steroids"},{"key":"10.1016\/j.trre.2017.08.002_bb0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/014107687807101006","article-title":"Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women","volume":"71","author":"Crilly","year":"1978","journal-title":"J R Soc Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mpo.10334","article-title":"Biology of the basic multicellular unit and the pathophysiology of osteoporosis","volume":"41","author":"Jilka","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.trre.2017.08.002_bb0180","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.2009-0205","article-title":"Approach to the patient with transplantation-related bone loss","volume":"94","author":"Ebeling","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2017.08.002_bb0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1432-2277.1995.tb01503.x","article-title":"Timing and quantification of bone loss in cardiac transplant recipients","volume":"8","author":"Van Cleemput","year":"1995","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0190","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0195","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1210\/endo.137.6.8641176","article-title":"T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia","volume":"137","author":"Buchinsky","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.trre.2017.08.002_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bone.2004.02.009","article-title":"Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures","volume":"35","author":"Igarashi","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.trre.2017.08.002_bb0205","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00007890-199404270-00016","article-title":"The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo","volume":"57","author":"Cvetkovic","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.002_bb0210","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","article-title":"Calcineurin\/NFAT signaling in osteoblasts regulates bone mass","volume":"10","author":"Winslow","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.trre.2017.08.002_bb0215","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","article-title":"NFAT and Osterix cooperatively regulate bone formation","volume":"11","author":"Koga","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0220","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.transproceed.2017.02.023","article-title":"Understanding bone damage after kidney transplantation: a retrospective monocentric cross sectional analysis","volume":"49","author":"Gregorini","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.002_bb0225","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1093\/ndt\/gfr214","article-title":"Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease","volume":"26","author":"Westenfeld","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0230","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bone.2004.07.013","article-title":"Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts","volume":"35","author":"Kneissel","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.trre.2017.08.002_bb0235","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1111\/j.1399-0012.2010.01231.x","article-title":"Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study","volume":"24","author":"Dolgos","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2017.08.002_bb0240","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","article-title":"Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?","volume":"23","author":"Kwok","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0245","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurjhf\/hfs002","article-title":"Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance","volume":"14","author":"Terrovitis","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.trre.2017.08.002_bb0250","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-06-0614","article-title":"Effects of calcium supplementation on bone loss and fractures in congestive heart failure","volume":"156","author":"Frost","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.trre.2017.08.002_bb0255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jphotobiol.2010.04.001","article-title":"Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR)","volume":"101","author":"Reichrath","year":"2010","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.trre.2017.08.002_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11938-017-0115-5","article-title":"Clinical implications of emerging data on the safety of proton pump inhibitors","volume":"15","author":"Schnoll-Sussman","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.trre.2017.08.002_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0270","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00198-003-1435-y","article-title":"Relationship between age, renal function and bone mineral density in the US population","volume":"14","author":"Klawansky","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0275","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.transproceed.2012.09.117","article-title":"Bone density in heart or lung transplant recipients--a longitudinal study","volume":"45","author":"Wang","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.002_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","article-title":"Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure","volume":"103","author":"Shane","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0285","first-page":"116","article-title":"Bone loss after heart transplantation: a prospective study","volume":"13","author":"Sambrook","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0290","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(95)92748-4","article-title":"Bone mineral loss and recovery after cardiac transplantation","volume":"346","author":"Henderson","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2017.08.002_bb0295","first-page":"1497","article-title":"Bone loss and turnover after cardiac transplantation","volume":"82","author":"Shane","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2017.08.002_bb0300","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2007-1876","article-title":"Bone mineral density changes during the menopause transition in a multiethnic cohort of women","volume":"93","author":"Finkelstein","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2017.08.002_bb0305","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.amepre.2004.02.013","article-title":"Modifiable predictors of bone loss in older men: a prospective study","volume":"26","author":"Bakhireva","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-2895-8_7","article-title":"Glucocorticoids and skeletal muscle","volume":"872","author":"Bodine","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.trre.2017.08.002_bb0315","first-page":"1740","article-title":"Fracture after cardiac transplantation: a prospective longitudinal study","volume":"81","author":"Shane","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2017.08.002_bb0320","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1432-2277.2007.00598.x","article-title":"Unexpected low incidence of vertebral fractures in heart transplant recipients: analysis of bone turnover","volume":"21","author":"Kerschan-Schindl","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0325","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","article-title":"Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study","volume":"357","author":"Leidig-Bruckner","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2017.08.002_bb0330","first-page":"215","article-title":"Relationship between various measures of bone mineral density and vertebral fractures in cardiac transplant recipients","volume":"134","author":"Hofle","year":"2004","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.trre.2017.08.002_bb0335","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.trre.2017.08.002_bb0340","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11914-010-0032-1","article-title":"The utility and limitations of FRAX: a US perspective","volume":"8","author":"Silverman","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.trre.2017.08.002_bb0345","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trre.2017.08.002_bb0350","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","article-title":"From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates","volume":"75","author":"Rogers","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0355","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trre.2017.08.002_bb0360","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","article-title":"Osteoblast proliferation and maturation by bisphosphonates","volume":"25","author":"Im","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.trre.2017.08.002_bb0365","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2017.08.002_bb0370","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","article-title":"A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis","volume":"23","author":"Lekamwasam","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0375","first-page":"Cd003376","article-title":"Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trre.2017.08.002_bb0380","first-page":"Cd001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trre.2017.08.002_bb0385","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0390","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1359\/jbmr.2003.18.5.919","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium","volume":"18","author":"Sambrook","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0395","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7182\/pit2012969","article-title":"Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3","volume":"22","author":"Gilfraguas","year":"2012","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0400","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00007890-199605270-00015","article-title":"Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D","volume":"61","author":"Van Cleemput","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.002_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2013\/837573","article-title":"Bisphophonates in CKD patients with low bone mineral density","volume":"2013","author":"Liu","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.trre.2017.08.002_bb0410","first-page":"324","article-title":"Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays","volume":"60","author":"Brown","year":"2014","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.trre.2017.08.002_bb0415","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ajcn\/44.2.287","article-title":"Calcium supplements in the prevention of steroid-induced osteoporosis","volume":"44","author":"Reid","year":"1986","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trre.2017.08.002_bb0420","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin","volume":"328","author":"Sambrook","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0425","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-004-1621-6","article-title":"The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report","volume":"15","author":"Boonen","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0430","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/eje.1.01841","article-title":"Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects","volume":"152","author":"Bonadonna","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.trre.2017.08.002_bb0435","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.beem.2015.06.001","article-title":"Vitamin D signaling in calcium and bone homeostasis: a delicate balance","volume":"29","author":"Carmeliet","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.trre.2017.08.002_bb0440","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1399-0012.2009.00989.x","article-title":"Severe vitamin D deficiency among heart and liver transplant recipients","volume":"23","author":"Stein","year":"2009","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2017.08.002_bb0445","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/derm.20731","article-title":"Influence of drugs on vitamin D and calcium metabolism","volume":"4","author":"Grober","year":"2012","journal-title":"Dermato-endocrinology"},{"key":"10.1016\/j.trre.2017.08.002_bb0450","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00041552-200403000-00004","article-title":"The association between congestive heart failure and chronic renal disease","volume":"13","author":"Silverberg","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.trre.2017.08.002_bb0455","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1359\/jbmr.2000.15.9.1818","article-title":"Effect of calcitriol on bone loss after cardiac or lung transplantation","volume":"15","author":"Sambrook","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0460","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1359\/jbmr.2001.16.3.565","article-title":"Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation","volume":"16","author":"Henderson","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0465","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","article-title":"Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation","volume":"350","author":"Shane","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0470","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","article-title":"Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies","volume":"25","author":"Reid","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0475","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0480","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00198-016-3858-2","article-title":"Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report","volume":"28","author":"Fahrleitner-Pammer","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0485","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide on early bone loss after kidney transplantation","volume":"8","author":"Cejka","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0490","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-3565(24)38923-2","article-title":"Molecular mechanisms of selective estrogen receptor modulator (SERM) action","volume":"295","author":"Dutertre","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trre.2017.08.002_bb0495","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/jbmr.5650110819","article-title":"Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A\u2014induced osteopenia in oophorectomized rats","volume":"11","author":"Bowman","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0500","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.2010.143453","article-title":"Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial","volume":"70","author":"Mok","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trre.2017.08.002_bb0505","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1754045313489645","article-title":"The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy","volume":"19","author":"Panay","year":"2013","journal-title":"Menopause Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0510","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM199803123381107","article-title":"Treatment of postmenopausal osteoporosis","volume":"338","author":"Eastell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.002_bb0515","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2017.08.002_bb0520","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2017.08.002_bb0525","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijcard.2011.12.075","article-title":"High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients","volume":"155","author":"Serra","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trre.2017.08.002_bb0530","series-title":"Questions and answers on the review of calcitonincontaining medicines - outcome of a procedure under Article 31 of Directive 2001\/83\/EC","year":"2013"},{"key":"10.1016\/j.trre.2017.08.002_bb0535","unstructured":"Questions and answers: changes to the indicated population for miacalcin (calcitonin-salmon), U. S. Food & Drug Administration, U. S. Department of Health and Human Services, Silver Spring, United States."},{"key":"10.1016\/j.trre.2017.08.002_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001343","article-title":"Calcitonin for preventing and treating corticosteroid-induced osteoporosis","volume":"2","author":"Cranney","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trre.2017.08.002_bb0545","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.healun.2004.02.016","article-title":"Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation","volume":"24","author":"Kapetanakis","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0550","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S1053-2498(02)01184-1","article-title":"Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients","volume":"22","author":"Braith","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0555","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/01.tp.0000176927.43937.bb","article-title":"Comparison of calcitonin versus calcitonin+resistance exercise as prophylaxis for osteoporosis in heart transplant recipients","volume":"81","author":"Braith","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.002_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0565","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1600-6143.2005.00809.x","article-title":"Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers","volume":"5","author":"Mehra","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0570","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02390832","article-title":"A meta-analysis of the effects of cigarette smoking on bone mineral density","volume":"68","author":"Ward","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.trre.2017.08.002_bb0575","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12889-016-3465-3","article-title":"Accumulation of material and lifestyle problems among daily smokers in Norway 1999 to 2013 - a cross-sectional analysis","volume":"16","author":"Saebo","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.trre.2017.08.002_bb0580","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.transproceed.2007.06.067","article-title":"Impact of smoking on survival after heart transplantation","volume":"39","author":"Sanchez-Lazaro","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.002_bb0585","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1530-0277.2000.tb01971.x","article-title":"Skeletal response to alcohol","volume":"24","author":"Turner","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0590","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/152692480101100410","article-title":"Substance abuse in heart transplant recipients: a 10-year follow-up study","volume":"11","author":"Hanrahan","year":"2001","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0595","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jbmr.2017","article-title":"A meta-analysis of the association of fracture risk and body mass index in women","volume":"29","author":"Johansson","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2017.08.002_bb0600","doi-asserted-by":"crossref","first-page":"e5290","DOI":"10.1097\/MD.0000000000005290","article-title":"Body mass index and the risk of low bone mass-related fractures in women compared with men: a PRISMA-compliant meta-analysis of prospective cohort studies","volume":"96","author":"Xiang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.trre.2017.08.002_bb0605","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.healun.2004.08.010","article-title":"Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change","volume":"24","author":"Grady","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.002_bb0610","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.hrtlng.2016.03.005","article-title":"Clinical outcomes in overweight heart transplant recipients","volume":"45","author":"Jalowiec","year":"2016","journal-title":"Heart Lung"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X17300393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X17300393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T22:44:18Z","timestamp":1750805058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X17300393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0955470X17300393"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2017.08.002","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis following heart transplantation and immunosuppressive therapy","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}